ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

Also in This 8-page Issue: In Overhaul of Ethics Rules, NIH Bans Employees From Consulting for and Owning Stock in Biomedical Companies.

February 4, 2005

ONS Membership Still Climbing, Soars over 15,000

June 23, 1989

“Evolving Concept” Looks At Appropriate Early Decision Making In Patient Management

September 28, 1984

FDA: Silicone Breast Implants Safe, But Not “Lifetime Device”

June 24, 2011

NCI CTEP Approved Trials For the Month of January

January 25, 2013

NCI Seeks 150 Advocates For Advice On Plans, Policies.

March 2, 2001